
Rafaxone SB 250mg/125mg Injection
Marketer
Aarcin Pharmaceutical LLP
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview Rafaxone SB 250mg/125mg Injection
Combiflox, a 250mg/125mg injectable formulation, combats bacterial infections by inhibiting microbial growth and spread. Administration must be overseen by a medical professional; consistent adherence to the prescribed regimen is crucial, even with symptom improvement, to ensure treatment efficacy. Abrupt cessation may compromise its effectiveness. Commonly reported side effects include nausea, vomiting, diarrhea, and dyspepsia. Worsening side effects warrant immediate medical attention. Seek immediate medical help for allergic reactions (e.g., rash, pruritus, edema, dyspnea). Inform your doctor of all current medications, especially if pregnant or breastfeeding, before commencing treatment. Alcohol consumption should be avoided due to potential increased drowsiness. While generally not impairing driving ability, avoid driving if experiencing drowsiness or dizziness. Adequate rest, a nutritious diet, and hydration are recommended for optimal recovery. Your physician may order laboratory tests to monitor treatment response.
Uses of Rafaxone SB 250mg/125mg Injection
Infections caused by bacteria
Major Benefits of Rafaxone SB 250mg/125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Rafaxone SB 250mg/125mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Rafaxone SB 250mg/125mg Injection:
The medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Rafaxone SB 250mg/125mg Injection works:
Ceftriaxone and Sulbactam, combined as Rafaxone SB 250mg/125mg Injection, offer a dual-action antibacterial approach. Ceftriaxone, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, hindering their ability to survive. Sulbactam, a beta-lactamase inhibitor, complements this by countering bacterial resistance mechanisms, thereby maximizing Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Ingestion of alcohol alongside Rafaxone SB 250mg/125mg Injection presents no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable formulation of Rafaxone SB (250mg/125mg) is typically regarded as safe for use in pregnancy. Preclinical trials in animals have revealed minimal or no harmful consequences for fetal development; nevertheless, data from human studies are scarce.
Breast feedingCAUTION
Administering Rafaxone SB 250mg/125mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Rafaxone SB 250mg/125mg Injection can induce drowsiness, visual disturbances, and dizziness. Refrain from operating a vehicle if these effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Rafaxone SB 250mg/125mg Injection to individuals with renal impairment. Seek medical advice from your physician.
LiverCAUTION
Exercise caution when administering Rafaxone SB 250mg/125mg Injection to individuals with severe hepatic impairment; dosage modification may be necessary. A physician's consultation is advised. Altering the Rafaxone SB 250mg/125mg Injection dose is not suggested for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Rafaxone SB 250mg/125mg Injection :
Should you forget a scheduled dose of Rafaxone SB 250mg/125mg Injection, seek medical advice.
Facts to Know About Rafaxone SB 250mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
